Liquid-liquid phase separation in cancer radiotherapy and immunotherapy: emerging roles and translational opportunities

IF 42.2 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Chenchen Dong,Cong Shang,Bing Han,Ziyi Liu,Jiaoyang Wang,Peng Cao,Juan Zeng,Ayao Guo,Xiufang Ren,Shuo Cao
{"title":"Liquid-liquid phase separation in cancer radiotherapy and immunotherapy: emerging roles and translational opportunities","authors":"Chenchen Dong,Cong Shang,Bing Han,Ziyi Liu,Jiaoyang Wang,Peng Cao,Juan Zeng,Ayao Guo,Xiufang Ren,Shuo Cao","doi":"10.1186/s12943-026-02813-4","DOIUrl":null,"url":null,"abstract":"Abstract Liquid-liquid phase separation (LLPS) is a physicochemical process through which biomolecules assemble into membraneless condensates via weak, multivalent interactions. LLPS has emerged as a central biological principle that helps explain intracellular spatiotemporal compartmentalization, signal transduction, and stress responses. Dysregulated LLPS contributes to tumor initiation, progression, immune evasion, and treatment resistance; however, its cell-type-specific functions and relevance to radiotherapy and immunotherapy remain incompletely integrated. In this review, we critically synthesize recent mechanistic and translational advances linking LLPS to cancer radiotherapy and immunotherapy. Condensates may either support therapeutic resistance and immune evasion or enhance radiosensitivity and antitumor immunity, depending on their molecular composition, subcellular localization, cell type, and treatment context. We examine how condensate regulation connects radiation-induced DNA damage repair with innate immune activation and evaluate emerging therapeutic strategies that target disease-associated condensates. We also assess LLPS-associated abnormal condensates as candidate biomarkers for prognosis and prediction of tumor response to radiotherapy and immunotherapy. Tissue-specific LLPS regulation across tumor types, dynamic condensate remodeling under therapeutic stress, and rational strategies combining phase-separation modulation with immune-checkpoint inhibitors and radiotherapy require further investigation. Integrating multi-omics data with artificial intelligence-based algorithms may help construct systematic LLPS-related therapeutic-event maps and predictive models, thereby prioritizing experimentally testable hypotheses for personalized cancer management. With rigorous mechanistic validation and prospective clinical evaluation, selective modulation of disease-associated condensates may enhance radiosensitivity and strengthen antitumor immunity.","PeriodicalId":19000,"journal":{"name":"Molecular Cancer","volume":"22 1","pages":""},"PeriodicalIF":42.2000,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12943-026-02813-4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Liquid-liquid phase separation (LLPS) is a physicochemical process through which biomolecules assemble into membraneless condensates via weak, multivalent interactions. LLPS has emerged as a central biological principle that helps explain intracellular spatiotemporal compartmentalization, signal transduction, and stress responses. Dysregulated LLPS contributes to tumor initiation, progression, immune evasion, and treatment resistance; however, its cell-type-specific functions and relevance to radiotherapy and immunotherapy remain incompletely integrated. In this review, we critically synthesize recent mechanistic and translational advances linking LLPS to cancer radiotherapy and immunotherapy. Condensates may either support therapeutic resistance and immune evasion or enhance radiosensitivity and antitumor immunity, depending on their molecular composition, subcellular localization, cell type, and treatment context. We examine how condensate regulation connects radiation-induced DNA damage repair with innate immune activation and evaluate emerging therapeutic strategies that target disease-associated condensates. We also assess LLPS-associated abnormal condensates as candidate biomarkers for prognosis and prediction of tumor response to radiotherapy and immunotherapy. Tissue-specific LLPS regulation across tumor types, dynamic condensate remodeling under therapeutic stress, and rational strategies combining phase-separation modulation with immune-checkpoint inhibitors and radiotherapy require further investigation. Integrating multi-omics data with artificial intelligence-based algorithms may help construct systematic LLPS-related therapeutic-event maps and predictive models, thereby prioritizing experimentally testable hypotheses for personalized cancer management. With rigorous mechanistic validation and prospective clinical evaluation, selective modulation of disease-associated condensates may enhance radiosensitivity and strengthen antitumor immunity.
液-液相分离在癌症放疗和免疫治疗中的作用和转化机会
液-液相分离(LLPS)是生物分子通过弱多价相互作用组装成无膜凝聚体的物理化学过程。LLPS已成为一个中心生物学原理,有助于解释细胞内时空区隔、信号转导和应激反应。失调的LLPS有助于肿瘤的发生、发展、免疫逃避和治疗抵抗;然而,它的细胞类型特异性功能和与放疗和免疫治疗的相关性仍然不完全整合。在这篇综述中,我们批判性地综合了最近将LLPS与癌症放疗和免疫治疗联系起来的机制和翻译进展。冷凝物可能支持治疗抵抗和免疫逃避,也可能增强放射敏感性和抗肿瘤免疫,这取决于它们的分子组成、亚细胞定位、细胞类型和治疗环境。我们研究冷凝物调节如何将辐射诱导的DNA损伤修复与先天免疫激活联系起来,并评估针对疾病相关冷凝物的新兴治疗策略。我们还评估了llps相关的异常凝析物作为预后和预测肿瘤对放疗和免疫治疗反应的候选生物标志物。跨肿瘤类型的组织特异性LLPS调节、治疗应激下的动态凝聚重塑以及相分离调节与免疫检查点抑制剂和放疗相结合的合理策略需要进一步研究。将多组学数据与基于人工智能的算法相结合,可能有助于构建系统的llps相关治疗事件图和预测模型,从而优先考虑实验可验证的个性化癌症管理假设。经过严格的机制验证和前瞻性临床评估,选择性调节疾病相关冷凝物可能增强放射敏感性和增强抗肿瘤免疫。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Cancer
Molecular Cancer 医学-生化与分子生物学
CiteScore
54.90
自引率
2.70%
发文量
224
审稿时长
2 months
期刊介绍: Molecular Cancer is a platform that encourages the exchange of ideas and discoveries in the field of cancer research, particularly focusing on the molecular aspects. Our goal is to facilitate discussions and provide insights into various areas of cancer and related biomedical science. We welcome articles from basic, translational, and clinical research that contribute to the advancement of understanding, prevention, diagnosis, and treatment of cancer. The scope of topics covered in Molecular Cancer is diverse and inclusive. These include, but are not limited to, cell and tumor biology, angiogenesis, utilizing animal models, understanding metastasis, exploring cancer antigens and the immune response, investigating cellular signaling and molecular biology, examining epidemiology, genetic and molecular profiling of cancer, identifying molecular targets, studying cancer stem cells, exploring DNA damage and repair mechanisms, analyzing cell cycle regulation, investigating apoptosis, exploring molecular virology, and evaluating vaccine and antibody-based cancer therapies. Molecular Cancer serves as an important platform for sharing exciting discoveries in cancer-related research. It offers an unparalleled opportunity to communicate information to both specialists and the general public. The online presence of Molecular Cancer enables immediate publication of accepted articles and facilitates the presentation of large datasets and supplementary information. This ensures that new research is efficiently and rapidly disseminated to the scientific community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书